Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC

Clinical trial NCT00321334 · COMPLETED

Trial details

NCT number: NCT00321334
Sponsor: Chinese Society of Lung Cancer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2006-03-01
Primary completion: 2013-12-01
Enrollment: 410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.